Real-time enrollment status for this platinum-resistant ovarian cancer clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:46 AM UTC
| NCT Number | NCT06515613 |
| Recruiting Status | Recruiting |
| Condition | Platinum-resistant Ovarian Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 156 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Context Therapeutics Inc. |
| Last Updated on CT.gov | June 16, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT06515613 is currently recruiting participants. This clinical trial study for platinum-resistant ovarian cancer is actively seeking new participants at 13 locations across the United States. The study is sponsored by Context Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06515613 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06515613 was last updated 3 weeks ago (June 16, 2026). HelloStudys verifies this status automatically.